 | ||||||||
| "anti diabetes" | ||||||||
| NEWS | ||||||||
Mylan A Tough Contender In The Biosimilar Anti-Diabetes Race Mylan Inc. (MYL) has become a tough competitor in the biosimilar glargine race after announcing that it will begin Phase-III trials to show the ...
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.